BioNTech, Pfizer say test shows 3 doses of vaccine neutralize Omicron

This advertisement has not loaded yet, but your article continues below. BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was shown to generate a neutralizing effect against the new Omicron variant in a laboratory test. In the first official statement from vaccine manufacturers on the likely efficacy of their shot against Omicron, BioNTech and Pfizer said in a joint statement that two vaccine doses resulted in significantly lower neutralizing antibodies but that a third dose of their vaccine increased the neutralizing antibodies by a factor of 25. They added that, if needed, they can deliver an Omicron-based vaccine in March 2022. (Reporting by Ludwig Burger; editing by Jason Neely) This advertisement has not loaded yet, but your article continues below.
https://financialpost.com/pmn/business-pmn/biontech-pfizer-say-test-shows-3-doses-of-vaccine-neutralize-omicron